Penumbra Inc (STU:0P8)
€ 212.2 2.5 (1.19%) Market Cap: 8.20 Bil Enterprise Value: 8.14 Bil PE Ratio: 266.87 PB Ratio: 7.97 GF Score: 87/100

Penumbra Inc at Citi Healthcare Services, Medtech, Tools, & HCIT Virtual Conference Transcript

Feb 24, 2021 / 08:20PM GMT
Release Date Price: €236 (+3.51%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Hello, everybody, welcome back for the last medtech session of the day, and we are here with the management team of Penumbra. And Adam, thank you so much for joining us as well as the rest of your team at the Citibank Virtual Healthcare Conference.

Adam Elsesser
Penumbra, Inc. - Co-Founder, Chairman, President & CEO

Yes. Well, thanks for having us. Glad to be here.

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Good. It was -- one of the things you and I talked about briefly last night after the earnings call was this sort of subtle but polite, "Joanne, our vascular revenue was greater than our neurovascular revenue now." And I was like, yes, I know that. I know that. But it was a really polite way of reminding me of saying the company has changed a lot. I mean this isn't the stroke company that IPO-ed a couple of years ago. It's evolved.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot